The acquisition of methamphetamine for approved research or therapeutic purposes presents unique challenges for institutions. Verifying compliance with federal statutes and rigorous reporting demands is absolutely critical. This process often involves precise record documentation, strict stock controls, and periodic audits. Moreover, institutions m